[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) filing a Form 144 notifies the proposed sale of 101,429 shares of common stock with an aggregate market value of $405,980.00. The shares were acquired on 02/20/2024 by lapse of restricted stock as equity compensation from Blend Labs, Inc. The proposed sale is to be effected through Charles Schwab & Co., Inc. on or about 09/05/2025 on the NYSE. Total shares outstanding reported are 255,696,747. The filer certifies they do not possess undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Insider plans to sell a small equity award acquired via restricted stock lapse; size is immaterial to market cap.

The filing shows an insider intends to sell 101,429 shares worth about $406k acquired on 02/20/2024 through restricted stock lapse as equity compensation. Relative to 255.7 million shares outstanding, this represents roughly 0.04% of the share count, indicating low immediate dilution or market impact. The sale is routed via Charles Schwab and scheduled around 09/05/2025. No recent sales in the past three months are reported. This is a routine disclosure under Rule 144 rather than a corporate operational update.

Corporate Governance Expert

TL;DR: This is a standard Rule 144 notification for insider resale of vested equity; it affirms compliance and absence of undisclosed material info.

The form documents that the securities were acquired through equity compensation and that the filer attests to lacking material nonpublic information. The presence of a broker and a specified approximate sale date aligns with standard Rule 144 procedures. There are no indications of a trading plan date or 10b5-1 reliance included in the remarks. From a governance perspective, the disclosure satisfies reporting requirements but contains no new operational or control-related information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	101429	405980.00	255696747	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2024	Restricted Stock Lapse - See Remarks	BLEND LABS, INC.			101429	02/20/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Blend Labs' (BLND) Form 144 report?

The Form 144 reports a proposed sale of 101,429 common shares valued at $405,980.00 to be sold around 09/05/2025 on the NYSE.

How were the shares acquired that are being sold?

The shares were acquired on 02/20/2024 by restricted stock lapse as equity compensation from Blend Labs, Inc.

Through which broker will the BLND shares be sold?

The filing lists Charles Schwab & Co., Inc. as the broker for the proposed sale.

How large is the proposed sale relative to shares outstanding?

The proposed 101,429 shares compare to 255,696,747 shares outstanding, about 0.04% of the outstanding share count.

Did the filer report other securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.